| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |
| 09/07/2001 | WO2001064668A2 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |
| 09/07/2001 | WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents |
| 09/07/2001 | WO2001064640A1 2,3-dihydro-1h-indolinyl-alkanoic acids as cell adhesion inhibitors |
| 09/07/2001 | WO2001064639A2 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/07/2001 | WO2001055111A8 Biaryl compounds, their preparation and their use in therapy |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001000197A3 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 09/07/2001 | CA2401667A1 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/06/2001 | US20010020098 For labeling target molecules |
| 09/06/2001 | US20010020097 Treatment of Alzheimer's disease |
| 09/06/2001 | US20010020095 High affinity for D4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression |
| 09/06/2001 | US20010020036 Synergistic mixtures |
| 09/06/2001 | US20010020035 Certain fused pyrrolecarboxamides a new class of gaba brain receptor |
| 09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010019783 Organic electroluminescent device |
| 09/06/2001 | DE10007948A1 Color for fibers, especially for coloring human hair and in coloring and bleaching kit, contains carbonyl compound and 1,3,3-tri-substituted 2-methylene-indoline and 3H-indolium derivative |
| 09/05/2001 | EP1130584A2 Dipyrromethene-metal chelate compound and optical recording medium using thereof |
| 09/05/2001 | EP1130014A2 Process for the purification of imidoalkanpercarboxylic acids |
| 09/05/2001 | EP1129167A1 Bleaching compositions |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |
| 09/05/2001 | EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments |
| 09/05/2001 | EP1128845A1 Combinations comprising a beta-agonist and a further antdiabetic agent |
| 09/05/2001 | EP1067950A4 Neo-tryptophan |
| 09/05/2001 | EP0832061B1 Benzamide derivatives and their use as vasopressin antagonists |
| 09/05/2001 | EP0828740B1 2-azabicyclo[2.2.1]heptane derivatives, preparation and application thereof |
| 09/05/2001 | EP0777646B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0681572B1 Thiazolidinethione-activated polyalkylene oxides |
| 09/05/2001 | CN1311776A Quanternary ammonium compounds as anti-tussive agents |
| 09/05/2001 | CN1311775A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/05/2001 | CN1311679A Benzimidazole derivatives as modulators of IgE |
| 09/05/2001 | CN1311675A Compounds having IgE affecting properties |
| 09/05/2001 | CN1311184A Indole compounds and its synthetic method |
| 09/05/2001 | CN1070492C Tetracylic derivatives, process for prepn. of same and use |
| 09/05/2001 | CN1070478C Prepn. of solutions of imido-alkancaboxylic acids suitable for peroxidation processes |
| 09/05/2001 | CN1070477C Indole derivative |
| 09/04/2001 | US6284897 Method for crystallizing tryptophan |
| 09/04/2001 | US6284788 Use of known agonists of the central cannabinoid receptor CB1 |
| 09/04/2001 | CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 09/04/2001 | CA2056067C A physical form of n-¬4-¬5-(cyclopentyloxcarbony)-amino-1-methylindol-3-yl-methyi|-3-methoxybenzoy1|-2-methyibezenesulphonanide, processes for its preparation and compositions containing it |
| 08/30/2001 | WO2001063345A2 Photochemically controlled photonic crystal diffraction |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062705A2 Aminoalcohol derivatives |
| 08/30/2001 | WO2001062219A1 Agent for dyeing fibres comprising an indoline/indolium derivative |
| 08/30/2001 | WO2001062156A1 Novel indocyanine dyes |
| 08/30/2001 | US20010018525 Modulating blood glucose concentration |
| 08/30/2001 | US20010018441 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents |
| 08/30/2001 | US20010018423 Anticoagulant agents |
| 08/30/2001 | US20010018184 Heterogenous assay for pyrophosphate |
| 08/30/2001 | DE10009000A1 Verfahren zur Herstellung substituierter Indole A process for the preparation of substituted indoles |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/29/2001 | EP1127876A1 Process for the preparation of isoindoline |
| 08/29/2001 | EP1127874A2 Process for the preparation of substituted indoles |
| 08/29/2001 | EP1127869A1 Novel compounds and medicinal use thereof |
| 08/29/2001 | EP1126840A1 5ht(1) receptor agonists and metoclopramide for the treatment of migraine |
| 08/29/2001 | EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP0850241B1 Iridium-diphosphine complexes and process for the hydrogenation of imines |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310714A Substituted benzoylcyclohexandiones |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310706A Inhibitors of phospholipase enzymes |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310704A Hydroxamic acid derivatives and medicinal utilization thereof |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310174A Application of imino alkyl carboxylic acid using for producing percarboxylic acid and producing process |
| 08/29/2001 | CN1310171A New tricyclic derivate and their producing process |
| 08/29/2001 | CN1310169A Anils with nitric oxide synzyme inhibiting function |
| 08/29/2001 | CN1309964A Carbazole-alkoloid cell cycle inhibitor, cell death inducer and their preparation |
| 08/29/2001 | CN1070184C Process for reducing water and polar impurities in imido-alkanpercarboxylic acids |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281357 Headache therapy |
| 08/28/2001 | US6281323 Polyamideimide copolymer |
| 08/28/2001 | US6281241 Use of melatonin for the treatment of androgenetic alopecia |
| 08/28/2001 | US6281237 N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives |
| 08/28/2001 | US6281212 Chemokine receptor antagonists and methods of use therefor |
| 08/28/2001 | US6281211 Treating a disorder responsive to the blockade of sodium channels |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060814A2 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/23/2001 | WO2001007029A3 Substituted guanidines and the use thereof |
| 08/23/2001 | US20010016661 Indolealkanoic acid derivatives inhibits aldose reductase and useful for treating chronic complication associated with diabetes mellitus including diabetic cataracts, retinopathy, nephropathy and neuropathy |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/22/2001 | EP1125924A1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1124819A1 Method of lithiating five-membered heterocycles |